@Blueberrymgmnt @Cumulus51896691 @GolfNut48846224 @RAH00084 A nice literature review of Aldox to that effect: https://t.co/6fXjRrcG2B Worth noting how it also talks about other Dox-enhancing techniques: all which failed. But the past does not represent th
@Kyalimers @GolfNut48846224 @RAH00084 @Livinginthesurf @jivetur88775834 I presume you’ve seen this review of aldox ( 2019 ) but am posting it in case you haven’t From my ( limited ) understanding It appears there’s been no convincing gold standard P3 stu
RT @SarcomaAlliance: This technical abstract summarizes results of studies on aldoxorubicin for soft tissue sarcomas. No survival benefit h…
RT @SarcomaAlliance: This technical abstract summarizes results of studies on aldoxorubicin for soft tissue sarcomas. No survival benefit h…
RT @SarcomaAlliance: This technical abstract summarizes results of studies on aldoxorubicin for soft tissue sarcomas. No survival benefit h…
This technical abstract summarizes results of studies on aldoxorubicin for soft tissue sarcomas. No survival benefit has been shown over doxorubicin, but... https://t.co/pZzS48HZLh
RT @SuzieSiegel: Dr. Lee Cranmer notes that #aldoxorubicin helped patients with #leiomyosarcoma & #liposarcoma go longer without their canc…
RT @SuzieSiegel: Dr. Lee Cranmer notes that #aldoxorubicin helped patients with #leiomyosarcoma & #liposarcoma go longer without their canc…
RT @SuzieSiegel: Dr. Lee Cranmer notes that #aldoxorubicin helped patients with #leiomyosarcoma & #liposarcoma go longer without their canc…
Dr. Lee Cranmer notes that #aldoxorubicin helped patients with #leiomyosarcoma & #liposarcoma go longer without their cancer spreading (a k a PFS). https://t.co/TO2eUiofhm